(MedPage Today) — Hailed as breakthrough treatments at their 2013 debut, the number of direct-acting antiviral (DAA) prescriptions to treat hepatitis C virus (HCV) infections has plummeted by nearly two-thirds in the last decade, according to…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
